New Drug Applications Archive - September 2004
Get news by email or subscribe to our news feeds.
September 1, 2004
- Cilansetron NDA Filing Accepted for Priority Review by the FDA for the Treatment of Irritable Bowel Syndrome with Diarrhea Predominance
- Atrix and Fujisawa Submit New Drug Application for Acne Product
- Exenatide New Drug Application Accepted for Review by the FDA
- NDA for Cellegesic is Accepted for Review by FDA
September 2, 2004
September 8, 2004
- CoTherix, Inc. Announces Priority Review Designation by the FDA for Ventavis NDA
- FDA Accepts Entereg for Review
September 9, 2004
September 10, 2004
September 15, 2004
September 17, 2004
September 20, 2004
September 21, 2004
September 22, 2004
September 24, 2004
September 27, 2004
September 28, 2004
September 29, 2004
- Schwarz Pharma Submits Marketing Applications for its Rotigotine Patch 'Neupro'
- NovaDel NDA for Nitroglycerin Lingual Spray is Accepted for Review by FDA
